The US is poised to legalize cannabis in some form for the first time since 1937. The country’s leadership has been divided on how legalization should proceed, and he may be able to sway them into his favor with a radical new policy proposal: completely decriminalizing marijuana nationwide.
Will He Lead Govt Closer To Legalization? is a question that has been asked by many people. Federal legalization 2021 is the answer to this question. Read more in detail here: federal legalization 2021.
While Robert Califf did not express his views on marijuana while working for the FDA, he did recognize the plant’s medicinal potential in 2016 at a cannabis-focused research meeting.
The Food and Drug Administration may appoint a new commissioner who has firsthand knowledge of cannabis’ medicinal advantages.
President Joe Biden said on Friday that he intends to propose Dr. Robert Califf, a cardiologist and clinical trial expert, to be the next FDA commissioner. According to Marijuana Stocks, Califf, who served as FDA Director for a brief period during the Obama administration, was given a cannabis medicine by his doctor.
While Califf did not express his views on marijuana while at the FDA, he did recognize the plant’s medicinal potential in 2016 at a cannabis-focused research meeting.
“We recognize that marijuana and marijuana-derived products have a variety of potential applications. For instance, AIDS wasting, epilepsy, neuropathic pain, multiple sclerosis spasticity treatment, cancer, and chemotherapy-induced nausea,” Califf said. “And in my cardiology practice, I had the opportunity to prescribe some of this to people with severe heart failure who developed a wasting cachectic syndrome.”
Califf also said that, although the FDA must establish that botanical cannabis is “safe and effective for any indication,” this does not rule out the possibility of practical applications, and that additional research are likely to add to the body of knowledge on the subject. “No one has proved to FDA that any such product is safe or effective for the treatment of any illness or condition,” says the report. To address this, research including marijuana must be done to carefully analyze the safety and efficacy of marijuana for medicinal usage.”
“More studies, as well as a marketing application for review, are required to ensure that the drug product satisfies the statutory threshold for approval,” Califf said.
“This is what we really want, and we actively support and wish to collaborate with others to make it a reality,” he continued. “In order to do so, we know we need to make it easier for enterprises interested in bringing safe, effective, and high-quality goods to market, including scientifically-based research on these medical purposes.”
Califf said at the conference that the FDA has previously approved synthetic cannabis medicines such as Marinol.
Given all Califf has stated on the subject, one may infer that if he is elected commissioner, he will encourage the FDA to do more marijuana-related studies. And, given the FDA’s clout, it may wind up playing a key part in marijuana’s potential reclassification.
Furthermore, with the DEA raising production standards for psychedelics and descheduling cocaine-derived medications only last week, many cannabis activists are hopeful that marijuana will come next.
Watch This Video-
In 2021, the United States will vote on whether to legalize marijuana federally. If it passes, this will lead to many changes in the cannabis industry and government regulation. Reference: federal legalization 2021 vote.
- latest legalization news 2021
- federal legalization 2022
- federal legalization bill 2021 vote date
- federal legalization bill 2021 senate vote
- latest federal legalization news